Horse News

Donkey Skin Trade Threatens Welfare, Populations Worldwide

Posted by as published on The Horse

Derived from donkey skin, ejiao is used in traditional Chinese medicine. Demand for donkeys to meet its growing popularity has put the equids at risk

They come from Africa. Asia. South America. Australia. Europe. And yes, even North America.

A booming demand for a traditional Chinese medicine, ejiao, is driving up prices for donkeys across the globe, say donkey researchers and welfare experts. Meanwhile, donkeys themselves are paying a much higher price, with often “brutal” slaughter methods and “horrific” pre-slaughter conditions, those experts say.

“We’re seeing absolutely terrifying scenarios, mainly in developing countries,” said Faith Burden, PhD, director of research and operational support at The Donkey Sanctuary, in the U.K.

This includes herding donkeys for hundreds of miles with no rest, food, or water or transporting them on tightly packed trucks for 24 hours at a time, Burden said. Many are sick or injured, and pregnant jennies often abort their fetuses during the journeys, as her organization described in a recently released report on the trade, “Under the Skin.”

Skins From North America

American donkeys and wild burros are no exception to the trade, said Amy McLean, PhD, equine lecturer at the University of California, Davis. “I’m currently working with a donkey rescue organization to remove donkeys from park service lands because the park service can just go in and euthanize those animals, or somebody from China can just come buy them,” she said.

The increased demand has shot up donkey prices across the U.S., said Marjorie Farabee, equine manager at Todd Mission Ranch Rescue, which houses nearly 400 donkeys, mules, and horses in Plantersville, Texas, and director of Wild Burro Affairs at Wild Horse Freedom Federation. “American donkeys are being sold to kill buyers who take them over the border (for slaughter in Mexico and Canada),” she explained. “They’re being trucked over Eagle Pass (southwest Texas-Mexican border).”

Like donkeys in developing countries, American donkeys take long journeys—generally by truck—to supply the high demand for their skins in China, she said…(CONTINUED)

https://thehorse.com/184008/donkey-skin-trade-threatens-welfare-populations-worldwide/

10 replies »

  1. This is just more overwhelming news that touches the heart. My daughter has a donkey, most precious and loving animal. WE do not need animal skins for anything, vegan is great and the best to resolve this killing. I am against this!!!

    Liked by 1 person

  2. PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE

    Doctors’ Billboards Circulate at Brown Convocation
    Animal Use for Doctor Training Challenged

    “This use of live animals makes the emergency medicine residency at Brown University the last in New England,” said John Pippin, MD, FACC, Physicians Committee director of academic affairs. “Modernizing this training by switching to human-relevant methods would allow future patients to rest assured that their doctors were properly trained, using the best technologies available.”
    From 10:00 a.m. to 6:00 p.m., the three billboards will pass the Van Wickle Gates on Prospect Street approximately twice per hour.

    https://www.pcrm.org/news/news-releases/doctors-billboards-circulate-brown-convocation

    Like

  3. PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE
    Revolutionizing Drug Development With Human-Relevant Innovations: A Showcase and Briefing on Nonclinical Technologies

    On Thursday, September 19th, 2019, at 12:00 p.m., the Physicians Committee for Responsible Medicine hosted a congressional briefing in cooperation with Rep. Brendan Boyle (D-Pa.), featuring innovator companies showcasing cutting-edge technologies that have the potential to improve the safety and efficacy of pharmaceuticals while reducing animal testing. The event included a discussion on barriers to integration of these technologies into drug development and policy opportunities and concluded with a Q-and-A session.

    Many human diseases have no treatment options. Ninety-five percent of rare diseases have no approved treatment. More than 90 percent of new medicines fail in human clinical trials because they are unsafe or do not work, despite promising results in nonclinical animal tests. Modern, human-relevant tests that offer the possibility of more predictive data obtained more quickly and at less cost continue to emerge, yet are rarely used in regulatory decision-making due to barriers that will be discussed.
    https://www.pcrm.org/news/news-releases/revolutionizing-drug-development-human-relevant-innovations

    Liked by 1 person

Leave a Reply to Dianna Cancel reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.